Navigation Links
PCI Biotech-led Consortium Awarded EUR1.1 m Eurostars Grant for siRNA
Date:3/23/2009

OSLO, March 23 /PRNewswire/ -- PCI Biotech Holding ASA, the Norwegian drug delivery company, and siRNAsense AS, the Norwegian drug development company, today announced that a PCI Biotech-led consortium focused on effective siRNA cancer drug delivery has been ranked 3rd out of more than 300 European projects and will receive EUR 1.1 million in funding from the EU Eurostars Programme.

The consortium comprises three companies PCI Biotech, SpectraCure and siRNAsense and the project is entitled "Photochemical Internalisation for delivery of short interfering RNA (siRNA) - towards safe and specific cancer therapy". Competition was extremely fierce. All projects were assessed by carefully selected independent technical experts and an independent evaluation panel. They were then ranked across all industries based on an assessment of the project, technology and innovation, and market and competitiveness factors. The PCI Biotech-led project was ranked as number three of the 317 submitted applications. The three partners are contributing equally to the consortium.

The proposal came about because PCI Biotech, SpectraCure and siRNAsense were already aiming to develop their complementary technologies to fulfil unmet medical need in several disease areas, with cancer being a current focus area. The Eurostars' funding will now be used to develop a method for efficient light-directed delivery of siRNA to a variety of tumours. SiRNAs are compounds regulating gene expression in cells, with significant therapeutic and commercial potential; the realization of which urgently requires effective technologies for delivering siRNA into cells in the body.

Dr. Per Walday, CEO of PCI Biotech, comments: "The funding from Eurostars is an important milestone for PCI Biotech. The support provides financial backing in a critical phase of the development of the PCI technology, as well as an international collaborative opportunity between companies with innovative complementary technologies. We are very pleased that independent European experts share our view that photochemical internalisation has the potential to play an important role in future medical treatments based on siRNA."

Dr Hanne Mette Kristensen, CEO of siRNAsense adds: "This collaboration project will allow us to continue developing exciting new drug candidates for cancer indications. RNA interference is a new and very promising field, where delivery of the drug represents a big challenge. This funding will enable us to continue our investigation of effective ways of delivering siRNA based drugs to solid tumours. Combining PCI Biotech's technology with SpectraCure's fibreoptic dosimetry system will make it possible to enable homogeneous penetration throughout the various tumour layers."

    Corporate Inquiries:

    PCI Biotech ASA
    Per Walday
    tel: +47(0)23-25-4000
    Email: per.walday@pcibiotech.no

    siRNAsense AS
    Hanne Mette D. Kristensen
    tel: +47(0)22-95-8192
    E-mail: hannemette@sirnasense.com


'/>"/>
SOURCE PCI Biotech Holding ASA
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NewCardio Joins the Cardiac Safety Research Consortium
2. Genstruct Added to The Biomarker Consortiums Rapidly Growing Roster of Industry Experts
3. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
4. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
5. Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries
6. The Scripps Translational Science Institute Joins The MetaMiner Cardiac Consortium
7. Advanced Energy Consortium will develop micro and nanosensors to boost energy production
8. UTSA/UT lead national nanoscience consortium
9. Consortium publishes Phase II map of human genetic variation
10. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
11. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... ... 09, 2017 , ... The Giving Tree Wellness Center announces ... needs of consumers who are incorporating medical marijuana into their wellness and health ... As operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach ...
(Date:10/7/2017)... (PRWEB) , ... October 06, ... ... years’ experience providing advanced instruments and applications consulting for microscopy and surface ... expertise in application consulting, Nanoscience Analytical offers a broad range of contract ...
(Date:10/7/2017)... 6, 2017  The 2017 Nobel Prize in ... Jacques Dubochet, Joachim Frank and ... cryo-electron microscopy (cryo-EM) have helped to broaden ... biology community. The winners worked with systems manufactured ... produce highly resolved, three-dimensional images of protein structures ...
(Date:10/6/2017)... ... 06, 2017 , ... On Tuesday, October 24th, ABC² (Accelerate ... first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. ... open to the public, but registration is required. , WHAT: ABC² Brain ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):